ClearView Clears ACCC Hurdle as Zurich Buyout Moves Closer to Done
ClearView clears ACCC hurdle as Zurich acquisition moves closer to completion
ClearView Wealth Limited (ASX: CVW) has received a favourable determination from the Australian Competition and Consumer Commission (ACCC), confirming that Zurich Financial Services Australia Limited’s proposed acquisition of all ClearView shares may proceed. The determination was made during “phase 1” of the ACCC’s review under the new mandatory merger control regime that commenced 1 January 2026.
The ACCC Clearance Condition Precedent will be formally satisfied on expiry of the 14-day standstill period following publication of the determination, provided no review application is lodged. With this outcome, one of the most material regulatory hurdles in the deal’s path to completion has now been cleared.
When big ASX news breaks, our subscribers know first
What the ACCC clearance means and what comes next
Understanding the mandatory merger control regime
A scheme of arrangement is a court-supervised process by which a company’s shareholders vote to approve an acquisition. Under the proposed transaction, Zurich intends to acquire all ClearView shares via this mechanism, pursuant to a Scheme Implementation Deed (SID) announced to the ASX on 24 February 2026.
The new mandatory merger control regime, which commenced 1 January 2026, requires that certain acquisitions obtain ACCC clearance before they can proceed. This made ACCC Clearance a formal condition precedent under the SID. The fact that the determination was made during “phase 1” of the review is significant: it indicates that the ACCC identified no substantial competition concerns requiring a deeper, more protracted investigation.
The 14-day standstill period is a statutory window during which a third party may apply for a review of the ACCC’s determination. If no such application is made within that period, the ACCC Clearance Condition Precedent is formally satisfied and the transaction can advance to its remaining hurdles. The determination is also subject to the Scheme being implemented within 12 months of the determination date, in accordance with the Competition and Consumer Act 2010 (Cth).
Remaining conditions before the Scheme can be implemented
Three conditions precedent remain outstanding before the Scheme can be implemented:
- APRA Approval from the Australian Prudential Regulation Authority
- ClearView Shareholder approval at the Scheme Meeting, by the Requisite Majorities
- Court approval of the Scheme
ClearView and Zurich are continuing to work towards implementation in accordance with the indicative timetable outlined in the 24 February 2026 Transaction Announcement. Shareholders will be updated as required.
| Condition Precedent | Status | Notes |
|---|---|---|
| ACCC Clearance | Satisfied (pending 14-day standstill) | Determined in phase 1; no review application filed |
| APRA Approval | Pending | In progress |
| Shareholder Approval (Scheme Meeting) | Pending | Requisite Majorities required |
| Court Approval | Pending | Final step post-shareholder vote |
Board unanimously recommends the Scheme — major shareholder locked in
Director recommendation
The ClearView Board unanimously recommends that shareholders vote in favour of the Scheme at the Scheme Meeting. This recommendation is made in the absence of a Superior Proposal and subject to the Independent Expert concluding (and continuing to conclude) that the Scheme is in the best interests of ClearView Shareholders.
Each ClearView Director who holds or controls ClearView Shares has confirmed an intention to vote all such shares in favour of the Scheme at the Scheme Meeting, subject to the same qualifications.
Crescent Capital Partners’ 53% backing
Major Shareholder Support
Crescent Capital Partners, ClearView’s largest shareholder group, holds or controls the voting rights attached to 53.0% of ClearView Shares on issue and has confirmed in writing its intention to vote all of those shares in favour of the Scheme.
This support is subject to the Board continuing to unanimously recommend the Scheme, the Independent Expert continuing to conclude the Scheme is in shareholders’ best interests, no superior proposal emerging, and the Scheme being implemented within 12 months from the 24 February 2026 Transaction Announcement date.
The next major ASX story will hit our subscribers first
Investment thesis — what this milestone means for CVW shareholders
The ACCC clearance represents a meaningful de-risking event for the proposed transaction. A phase 1 determination, made without conditions, signals that the ACCC identified no substantial competition concerns, removing what many observers would have considered the most uncertain regulatory variable in the deal’s structure.
With 53.0% of ClearView Shares already committed to voting in favour by Crescent Capital Partners, the Scheme carries substantial momentum heading into the Scheme Meeting. That level of pre-committed support means the Requisite Majorities threshold is materially within reach, though shareholder approval, APRA clearance, and Court approval each remain outstanding.
ClearView has stated it will update shareholders on the implementation timetable as required. Investors should monitor those updates closely, as the path to completion now depends on the resolution of the three remaining conditions rather than regulatory intervention.
Stay Ahead on ASX Finance and Wealth Management News
Big News Blast delivers FREE breaking ASX news and in-depth analysis directly to your inbox within minutes of release. Over 20,000 subscribers are already getting market-moving updates the moment they hit the ASX. Click the “Free Alerts” button at StockWire X to make sure you never miss the next major deal or corporate milestone.